Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis
Authors
Keywords
Chronic kidney disease, Kidneys, Cardiovascular therapy, Death rates, Glomerular filtration rate, Uric acid, Creatinine, Proteinuria
Journal
PLoS One
Volume 12, Issue 11, Pages e0187550
Publisher
Public Library of Science (PLoS)
Online
2017-11-03
DOI
10.1371/journal.pone.0187550
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of Statin Therapy on Plasma Uric Acid Concentrations: A Systematic Review and Meta-Analysis
- (2016) Giuseppe Derosa et al. DRUGS
- Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers
- (2016) Michael Gillen et al. Drug Design Development and Therapy
- Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial
- (2015) Dipankar Sircar et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Allopurinol and Progression of CKD and Cardiovascular Events: Long-term Follow-up of a Randomized Clinical Trial
- (2015) Marian Goicoechea et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus
- (2015) M. J. Davies et al. DIABETES OBESITY & METABOLISM
- Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis
- (2015) Tahir Kanji et al. BMC Nephrology
- Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change
- (2014) John E. Cornell et al. ANNALS OF INTERNAL MEDICINE
- Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
- (2014) Josef Coresh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of uric-acid-lowering therapy on progression of chronic kidney disease: A meta-analysis
- (2014) Ye-fang Zhang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study
- (2014) Tatsuo Hosoya et al. Trials
- Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones
- (2013) D. S. Goldfarb et al. Clinical Journal of the American Society of Nephrology
- Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
- (2013) Bhadran Bose et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Hyperuricemia and the Progression of Chronic Kidney Disease: Is Uric Acid a Marker or an Independent Risk Factor?
- (2012) Khaled Nashar et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Atorvastatin therapy reduces serum uric acid levels: A meta-analysis of randomized controlled trials
- (2012) Hisato Takagi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Renal Function in Gout
- (2012) Andrew Whelton et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Elevated Serum Uric Acid Predicts Chronic Kidney Disease
- (2011) Tamaki Yamada et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- A Randomized Study of Allopurinol on Endothelial Function and Estimated Glomular Filtration Rate in Asymptomatic Hyperuricemic Subjects with Normal Renal Function
- (2011) M. Kanbay et al. Clinical Journal of the American Society of Nephrology
- Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment
- (2011) Yan Miao et al. HYPERTENSION
- Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
- (2011) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reporting of Conflicts of Interest in Meta-analyses of Trials of Pharmacological Treatments
- (2011) Michelle Roseman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Allopurinol Benefits Left Ventricular Mass and Endothelial Dysfunction in Chronic Kidney Disease
- (2011) M. P. Kao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Clinical Outcome of Hyperuricemia in IgA Nephropathy: A Retrospective Cohort Study and Randomized Controlled Trial
- (2011) Yongjun Shi et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Serum uric acid and chronic kidney disease: the Severance cohort study
- (2011) Y. Mok et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Uric Acid and Chronic Kidney Disease: New Understanding of an Old Problem
- (2011) Duk-Hee Kang et al. SEMINARS IN NEPHROLOGY
- Is High Serum Uric Acid a Risk Marker or a Target for Treatment? Examination of its Independent Effect in a Large Cohort With Low Cardiovascular Risk
- (2010) Chi Pang Wen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
- (2010) M. Goicoechea et al. Clinical Journal of the American Society of Nephrology
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Uric acid: A marker of increased cardiovascular risk
- (2008) Ana C.M. Gagliardi et al. ATHEROSCLEROSIS
- Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease
- (2008) S. D. Navaneethan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started